Eli Lilly and Company News - February 24, 2026

Eli Lilly Shares Slide as Novo Nordisk Signals 50% Price Cuts for GLP-1 Rivals

Eli Lilly (LLY) shares declined in premarket trading following a pricing announcement from primary rival Novo Nordisk. Novo Nordisk plans to reduce prices for...

Eli Lilly Stock Jumps on Zepbound KwikPen Approval as Rival Novo Nordisk Tumbles 16%

Eli Lilly and Company received U.S. FDA approval for the Zepbound KwikPen, a multi-dose injector for its weight-loss medication. This new device delivers four...